Abstract: A joint for a vehicle can direct forces away from an interior of the vehicle and along a frame rail. The joint can pivot when subjected to a high force, and the pivoting action can redirect and redistribute the force away from a passenger compartment. The joint can comprise multiple pivot points.

Abstract: An ink composition for photonic sintering and a method or producing the ink composition, the ink composition includes: metal nanoparticles comprising a first metal satisfying interaction formula 1; an organic non-aqueous binder; and a non-aqueous solvent. Interaction formula 1 is A1/A2?0.2, where A1/A2 is a ratio, in the x-ray photoelectron spectrum on the surface of the first metal, in which first metal 2p3/2 peak area of the oxide of the first metal (A1) is divided by first metal 2p3/2 peak area of the first metal (A2).

Abstract: Provided is a pharmaceutical composition for preventing or treating inflammatory bowel disease (IBD) comprising a mixed extract of at least two of Aucklandia lappa Decne, Terminalia chebula Retzius, and Zingiber officinale Rosc. as an active ingredient and a method thereof, and more specifically, to a pharmaceutical composition having an inhibitory effect on monocyte adhesion in intestinal epithelial cells, an effect of inhibiting the production of inflammatory cytokines, an effect of ameliorating colitis in an animal model of dextran sodium sulfate (DSS)-induced colitis, and an effect of ameliorating Crohn's disease in an animal model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced Crohn's disease.

Abstract: The disclosure relates to therapeutic proteins and pharmaceutical compositions comprising said proteins, which have utility in treating various human diseases. In particular aspects, the disclosed therapeutic proteins are useful for treating human gastrointestinal inflammatory diseases and gastrointestinal conditions associated with decreased epithelial cell barrier function or integrity. Further, the disclosed therapeutic proteins are useful for treating human inflammatory bowel disease, including inter alia, Crohn's disease and ulcerative colitis.

Abstract: This patent document relates to antibodies, antigen-binding antibody fragments (Fabs), and other protein scaffolds, directed against human antithrombin ? complexed with heparin and/or heparin-like structure (AT?H). These AT?H binding proteins can block the anti-coagulant activity of AT? to induce coagulation. Therapeutic uses of these antibodies and binders are described herein as are methods of panning and screening specific antibodies.

Abstract: An apparatus for generating animation includes: an input interface receiving a motion path sketch input and a posture sketch input from a user; a motion path information generator generating motion path information corresponding to the motion path sketch input; a posture information generator generating posture information corresponding to the posture sketch input; a similar motion clip retriever retrieving a similar motion clip corresponding to the posture information among motion clips stored in a database; a motion information generator generating motion information including a frame of the similar motion clip disposed according to the motion path information; and an animation generator generating animation by rendering a graphic model according to the motion information.

Abstract: An apparatus for generating a 3-dimensional character motion via timing transfer. The apparatus includes an example motion database configured to store data about one or more example motions of characters with an identical skeleton model structure; an example motion analyzer configured to generate a timing source by analyzing timing in a designated example motion data among the one or more example motion data stored in the example motion database; and an input motion transfer part configured to re-adjust spatial movements in an input motion in correspondence with the generated timing source so as to generate an output motion.

Abstract: Provided is a battery module, wherein heat-radiating plates are coupled to a plurality of battery cells stacked and arranged in the battery module so as to be closely adhered to both surfaces of each of the battery cells, curved parts are formed on both sides of each of the heat-radiating plates, adjacent heat-radiating plates are formed to be spaced apart from each other by a predetermined distance, such that a volume change caused by expansion of the battery cell and a dimensional tolerance of the battery cell itself may be absorbed, and cooling performance may be improved.

Abstract: Provided is a battery pack including a drainage system capable of efficiently discharging water collected inside the battery pack using buoyancy, preventing moisture permeation from the outside, and being implemented in a simple structure to maximize economical feasibility. The battery pack includes a battery pack case having a battery pack embedded therein and having a drainage hole formed in one side thereof; and a drainage system including a body provided to be concatenated with one side of the battery pack case of a position corresponding to the drainage hole and a floating body accommodated in the body and elevated by an introduced fluid to close the drainage hole.

Abstract: Described herein is a framework to facilitate vehicle position planning. In accordance with one aspect of the framework, transition information is determined based on the vehicle data, wherein the transition information includes pairs of starting and ending road segments and corresponding passenger states. Short-term demand for vehicles may be calculated based on the transition information and the historical transactional records. The short-term demand may then be used to generate a cruising recommendation.

Abstract: Provided herein are protein biomarkers for NETosis related diseases, including proteases. Also provided are substrate sequences of such proteases and uses thereof.

Abstract: This patent document relates to antibodies, antigen-binding antibody fragments (Fabs), and other protein scaffolds, directed against human antithrombin ? complexed with heparin and/or heparin-like structure (AT?H). These AT?H binding proteins can block the anti-coagulant activity of AT? to induce coagulation. Therapeutic uses of these antibodies and binders are described herein as are methods of panning and screening specific antibodies.

Abstract: This invention provides a device and a method of multi-view image calibration which can easily acquire calibration parameters (intrinsic/extrinsic parameter) of multi-image input device in wide space without separate calibration tool.

Abstract: A peptide that binds specifically to neuropilin-1 (NRP1) without binding to neuropilin-2 (NRP2) is provided. A fusion protein, a fusion antibody, small-molecule drug, a nanoparticle, or a liposome, which comprises the peptide, and a pharmaceutical composition for treating or preventing cancer or angiogenesis-related diseases, and a composition for diagnosing cancer or angiogenesis-related diseases are provided. A polynucleotide encoding the peptide that binds specifically to NRP1 and a method for screening the peptide that binds specifically to NRP1 are provided. An antibody heavy-chain constant region Fc-fused peptide binding specifically to NRP1 has the property of binding specifically to NRP1, and thus when it is administered in vivo, it accumulates selectively in tumor tissue, and widens the intercellular space between tumor-associated endothelial cells to promote its extravasation and increases its tumor tissue penetration.

Abstract: The present invention provides a method for fabricating a fluoride phosphor. A first solution is formed by dissolving potassium fluoride (KF) and either K2MnF6 or KMnO4 in a hydrofluoric acid solution. A second solution is formed by mixing a surfactant and a silane. The first solution and the second solution are mixed to form a precipitate. The precipitate is collected after the first solution and the second solution are mixed. The present invention also provides a fluoride phosphor represented by the following formula: K2[SiF6]:Mn4+. The fluoride phosphor has a particle size in a range of about 1 ?m to about 10 ?m. The present invention further provides a light-emitting apparatus and backlight module employing the same.

Abstract: An object trajectory tracking apparatus for tracking three-dimensional position of a high-speed moving instrument, i.e., a high-speed moving object for which it is difficult to acquire actual depth information, and a moving path thereof when information is extracted by utilizing a single depth sensor in a swing motion of sport in which a predetermined instrument is used by hand, and method therefor. The apparatus includes grid information generation unit, shadow area determination unit, initial object position information generation unit, object position estimation unit, and three-dimensional trajectory restoration unit, tracks three-dimensional route of an object, for which it is difficult to acquire depth information, in a fast sports motion such that information that allows user to correct and learn motion can be provided, and calculates a three-dimensional position and route calculated such that information required for practicing a more accurate swing motion can be provided.

Abstract: The present invention relates to an ethylene/alpha-olefin copolymer having excellent processability. The ethylene/alpha-olefin copolymer according to the present invention has excellent processability and is therefore suitable for producing products by an injection molding method.

Abstract: An apparatus for generating a 3-dimensional character motion via timing transfer. The apparatus includes an example motion database configured to store data about one or more example motions of characters with an identical skeleton model structure; an example motion analyzer configured to generate a timing source by analyzing timing in a designated example motion data among the one or more example motion data stored in the example motion database; and an input motion transfer part configured to re-adjust spatial movements in an input motion in correspondence with the generated timing source so as to generate an in output motion.

Abstract: Described herein is a descriptive framework to facilitate error detection in recognition data. In accordance with one aspect of the framework, at least one erroneous record is detected in a first set of recognition data. The framework may determine a correction of a first recognized identifier in the erroneous record by searching a second set of recognition data for a matching record with a second recognized identifier substantially similar to the first recognized identifier. A report may then be generated to present the detected erroneous record and the determined correction.